Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Patel N, Yancopoulos GD, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Abdulai RM, Robinson LB; NOTUS Study Investigators.
Bhatt SP, et al.
N Engl J Med. 2024 May 20. doi: 10.1056/NEJMoa2401304. Online ahead of print.
N Engl J Med. 2024.
PMID: 38767614